CymaBay Therapeutics, Inc.
Industry: Life Sciences ・ $CBAY on Nasdaq
Insider Sale
+$243,411
-43.04%
Shares
Shares Volume: 11,332 Shares
Average Share Price: $21.48
INSIDER
McWherter Charles
President of R&D (Officer)
reported on Dec 18 2023
traded on Dec 18 2023
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 15,000 |
| PURCHASES/SALES 1Y | 0 / 7 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $239,490.53 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 5 |
| PURCHASES/SALES 1Y | 0 / 27 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $317,896.96 |
| COMPANY PREVIOUS TRADES |